Genetic heterogeneity of autosomal dominant hypercholesterolemia in Mexico

被引:30
作者
Robles-Osorio, L
Huerta-Zepeda, A
Ordóñez, ML
Canizales-Quinteros, S
Díaz-Villaseñor, M
Gómez-Díaz, RA
Salinas, S
Ongay-Larios, L
Codiz-Huerta, G
Mora-Cabrera, M
Mehta, R
Pérez, FJG
Rull, JA
Rabès, JP
Tusié-Luna, MT
Durán-Vargas, S
Aguilar-Salinas, CA
机构
[1] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Endocrinol & Metab, Mexico City 14000, DF, Mexico
[2] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Mol Biol & Biotechnol, Mexico City 04510, DF, Mexico
[3] Univ Nacl Autonoma Mexico, Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Unidad Biol Mol & Med Genom, Mexico City 04510, DF, Mexico
[4] IMSS, Ctr Med Siglo XXI, Hosp Pediat, Mexico City, DF, Mexico
[5] IMSS, Ctr Med Siglo XXI, Hosp Cardiol, Mexico City, DF, Mexico
[6] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Unidad Biol Mol, Mexico City 04510, DF, Mexico
[7] Hop Necker Enfants Malad, INSERM, U383, Paris, France
关键词
apolipoprotein B; familial hypercholesterolemia; LDL receptor; Mexican families; PCSK9;
D O I
10.1016/j.arcmed.2005.04.018
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background. Familial hypercholesterolemia (FH) and familial defective apolipoprotein B-100 (FDB) are relatively common lipid disorders caused by mutations of the low-density lipoprotein receptor (LDLR) and apolipoprotein B (apoB) genes, respectively. A third locus on chromosome 1p34.1-p32 was recently linked to FH and the responsible gene has been identified [protein convertase subtilisin/kexin type 9 (PCSK9)]. Methods. We assessed the contribution of the LDLR, apoB, and PCSK9 genes as cause of FH in Mexico. Forty six unrelated probands, as well as 68 affected and 60 healthy relatives, were included. Results. All index cases were diagnosed as having heterozygous autosomal dominant FH. Seventeen of the 46 index cases had LDLR gene mutations, four of which were novel (Fs92ter108, C268R, Q718X, and Fs736ter743); and only one patient had an apoB mutation (R3500Q). We sequenced the PCSK9 gene in the remainder of the 28 probands with no identified LDLR or APOB gene defects; however, no PCSK9 mutations were found, including one large kindred with positive linkage to the 1p34.1-32 locus (multipoint LOD score of 3.3) and two small pedigrees. Linkage was excluded from these three loci in at least four kindreds suggesting that other yet uncharacterized genes are involved. Conclusions. Our results underline substantial genetic heterogeneity for FH in the Mexican population. (C) 2006 IMSS. Published by Elsevier Inc.
引用
收藏
页码:102 / 108
页数:7
相关论文
共 39 条
  • [1] Mutations in PCSK9 cause autosomal dominant hypercholesterolemia
    Abifadel, M
    Varret, M
    Rabès, JP
    Allard, D
    Ouguerram, K
    Devillers, M
    Cruaud, C
    Benjannet, S
    Wickham, L
    Erlich, D
    Derré, A
    Villéger, L
    Farnier, M
    Beucler, I
    Bruckert, E
    Chambaz, J
    Chanu, B
    Lecerf, JM
    Luc, G
    Moulin, P
    Weissenbach, J
    Prat, A
    Krempf, M
    Junien, C
    Seidah, NG
    Boileau, C
    [J]. NATURE GENETICS, 2003, 34 (02) : 154 - 156
  • [2] Aguilar-Salinas CA, 2001, J LIPID RES, V42, P1298
  • [3] BUFFONE GJ, 1985, CLIN CHEM, V31, P164
  • [4] Locus on chromosome 6p linked to elevated HDL cholesterol serum levels and to protection against premature atherosclerosis in a kindred with familial hypercholesterolemia
    Canizales-Quinteros, S
    Aguilar-Salinas, CA
    Reyes-Rodríguez, E
    Riba, L
    Rodríguez-Torres, M
    Ramírez-Jiménez, S
    Huertas-Vázquez, A
    Fragoso-Ontiveros, V
    Zentella-Dehesa, A
    Ventura-Gallegos, JL
    Vega-Hernández, G
    López-Estrada, A
    Aurón-Gómez, M
    Gomez-Perez, F
    Rull, J
    Cox, NJ
    Bell, GI
    Tusié-Luna, MT
    [J]. CIRCULATION RESEARCH, 2003, 92 (05) : 569 - 576
  • [5] Cenarro A, 1998, Hum Mutat, V11, P413, DOI 10.1002/(SICI)1098-1004(1998)11:5<413::AID-HUMU17>3.0.CO
  • [6] 2-F
  • [7] COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252
  • [8] Effect of atorvastatin on serum levels of lipoproteins in French Canadians with homozygous or compound heterozygous familial hypercholesterolemia
    Couture, P
    Gaudet, D
    Brun, D
    Bergeron, J
    Cantin, L
    Black, D
    Gagne, C
    [J]. ATHEROSCLEROSIS, 1997, 134 (1-2) : 54 - 54
  • [9] No genetic linkage or molecular evidence for involvement of the PCSK9, ARH or CYP7A1 genes in the Familial Hypercholesterolemia phenotype in a sample of Danish families without pathogenic mutations in the LDL receptor and apoB genes
    Damgaard, D
    Jensen, JM
    Larsen, ML
    Soerensen, VR
    Jensen, HK
    Gregersen, N
    Jensen, LG
    Faergeman, O
    [J]. ATHEROSCLEROSIS, 2004, 177 (02) : 415 - 422
  • [10] Molecular epidemiology of familial hypercholesterolaemia
    Defesche, JC
    Kastelein, JJP
    [J]. LANCET, 1998, 352 (9141) : 1643 - 1644